Kwangdong Healthbio Co., Ltd. (XKON:086220)
South Korea · Delayed Price · Currency is KRW 1,289.00
+92.00 (7.69%)
At close: Oct 23, 2026
Kwangdong Healthbio Market Cap
Kwangdong Healthbio has a market cap or net worth of 16.35 billion as of October 23, 2026. It is the 40,166th most valuable company in the world and the 2,525th biggest in South Korea. Its market cap has increased by 18.79% in one year.
Market Cap
16.35B
Enterprise Value
n/a
Revenue
38.10B
Global Rank
Country Rank
#2,525 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since April 5, 2017, Kwangdong Healthbio's market cap has decreased from 20.68B to 16.35B, a decrease of -20.90%. That is a compound annual growth rate of -2.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 16.35B | -18.11% |
| Dec 30, 2025 | 19.97B | 14.12% |
| Dec 30, 2024 | 17.50B | -38.70% |
| Dec 28, 2023 | 28.55B | 23.01% |
| Dec 29, 2022 | 23.21B | -12.02% |
| Dec 30, 2021 | 26.38B | -4.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharmsville | 26.62B |
| Baskhanbio Pharma | 24.95B |
| Seoul Pharma | 21.80B |
| Daesung Microbiological Labs. | 21.43B |
| WooGene B&G | 19.90B |
| Union Korea Pharm | 19.70B |
| BIFIDO | 19.67B |
| Hurum | 17.05B |